CA2291352A1 - Method of providing cosmetic/medical therapy - Google Patents
Method of providing cosmetic/medical therapy Download PDFInfo
- Publication number
- CA2291352A1 CA2291352A1 CA 2291352 CA2291352A CA2291352A1 CA 2291352 A1 CA2291352 A1 CA 2291352A1 CA 2291352 CA2291352 CA 2291352 CA 2291352 A CA2291352 A CA 2291352A CA 2291352 A1 CA2291352 A1 CA 2291352A1
- Authority
- CA
- Canada
- Prior art keywords
- electrically conductive
- recipient
- recited
- conductive liquid
- alternating current
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
Abstract
A method for preparing and use of a substance. The preparation of the substance involves a sequence passing a electrolytic substance, so as to change a physical property thereof. The prepared substance may be used for application to a subject when reduced skin wrinkles, tighter skin, and other benefits are desired.
Description
Case No.:
Pat. Appln.
D~ETHOD Oh PROVIDING COSD~ETIC / HHDICAL T8$R118Y
Field of the Iaveation The present invention relates generally to cosmetic/
medical therapy and more particularly to a method of io electrically preparing a substance with therapeutic qualities.
Backcround of the Invention The use of transcutaneous electrotherapy to provide therapy is well known. Transcutaneous electrotherapy involves the passage of an electrical current from one electrode to another, such that the therapeutic current is caused to pass directly through a target tissue of the patient. Exemplary devices used in the performance of transcutaneous 2o electrotherapy are provided in United States Patent Nos.
397,474; 3,794,022; 4,180,079; 4,446,870; 5,058,605; in French Patent 2621-827-A; and European Patent Application EP-377-057-A.
Although the use of transcutaneous electrotherapy has proven beneficial for some conditions, primarily for use on broken bones, such therapy suffers from inherent disadvantages.
For example, during transcutaneous electrotherapy, electrical current passes through the target tissue of the patient. Many patients may find this undesirable. The current tends to 3o concentrate where the electrodes are, making even distribution difficult. The amount of current that can be and is in fact generally used is quite low. Further, transcutaneous electrotherapy is generally not self-administrable, and therefore generally requires the presence of a skilled
Pat. Appln.
D~ETHOD Oh PROVIDING COSD~ETIC / HHDICAL T8$R118Y
Field of the Iaveation The present invention relates generally to cosmetic/
medical therapy and more particularly to a method of io electrically preparing a substance with therapeutic qualities.
Backcround of the Invention The use of transcutaneous electrotherapy to provide therapy is well known. Transcutaneous electrotherapy involves the passage of an electrical current from one electrode to another, such that the therapeutic current is caused to pass directly through a target tissue of the patient. Exemplary devices used in the performance of transcutaneous 2o electrotherapy are provided in United States Patent Nos.
397,474; 3,794,022; 4,180,079; 4,446,870; 5,058,605; in French Patent 2621-827-A; and European Patent Application EP-377-057-A.
Although the use of transcutaneous electrotherapy has proven beneficial for some conditions, primarily for use on broken bones, such therapy suffers from inherent disadvantages.
For example, during transcutaneous electrotherapy, electrical current passes through the target tissue of the patient. Many patients may find this undesirable. The current tends to 3o concentrate where the electrodes are, making even distribution difficult. The amount of current that can be and is in fact generally used is quite low. Further, transcutaneous electrotherapy is generally not self-administrable, and therefore generally requires the presence of a skilled
-2-operator. The administration of transcutaneous electrotherapy also tends to be costly, and generally does not offer a technique for the improvement of the cosmetic appearance of skin and soft tissue.
Other cosmetic procedures include such processes as surgical cut and lift operations, laser treatments, dermabrasion and chemical burns. These techniques have various disadvantages, such as cost, complexity, requiring trained operators or medical personnel, scarring, limited so effectiveness, ect.
In view of the foregoing, it is desirable to provide an effective alternative to transcutaneous electrotherapy wherein electric current is not caused to flow through the treated tissue of the patient, which is self-administrable, addresses cosmetic conditions such as wrinkling of the skin as well as medical conditions, and is comparatively easy to use.
~ummarv of the Iaveatfoa 2o The present invention specifically addresses and alleviates the above-mentioned deficiencies associated with the prior art. More particularly, the present invention comprises a method with a different approach for providing cosmetic/medical therapy, which is simple to administer, highly effective, and relatively low in cost. The steps include a process of preparing an electrically active substance which has unique benefits when administered to a subject. Administering the electrically activated substance to the subject provides a cosmetic/medical benefit to the subject.
3o Although, the subject as described herein, is a human being, the methodology of the present invention may be practiced upon various different animals with similar results.
Thus, the use of a human being in this application is by way of example only and not by way of limitation.
Other cosmetic procedures include such processes as surgical cut and lift operations, laser treatments, dermabrasion and chemical burns. These techniques have various disadvantages, such as cost, complexity, requiring trained operators or medical personnel, scarring, limited so effectiveness, ect.
In view of the foregoing, it is desirable to provide an effective alternative to transcutaneous electrotherapy wherein electric current is not caused to flow through the treated tissue of the patient, which is self-administrable, addresses cosmetic conditions such as wrinkling of the skin as well as medical conditions, and is comparatively easy to use.
~ummarv of the Iaveatfoa 2o The present invention specifically addresses and alleviates the above-mentioned deficiencies associated with the prior art. More particularly, the present invention comprises a method with a different approach for providing cosmetic/medical therapy, which is simple to administer, highly effective, and relatively low in cost. The steps include a process of preparing an electrically active substance which has unique benefits when administered to a subject. Administering the electrically activated substance to the subject provides a cosmetic/medical benefit to the subject.
3o Although, the subject as described herein, is a human being, the methodology of the present invention may be practiced upon various different animals with similar results.
Thus, the use of a human being in this application is by way of example only and not by way of limitation.
-3-The electrically activated substance is applied topically to skin to treat skin problems such as wrinkles, cuts, abrasions, etc. The electrically activated substance may also be ingested, so as to treat internal medical conditions.
According to the preferred embodiment of the present invention, the electrically activated substance is formed of a water base, preferably distilled water. However, other substances, particularly those comprised of simple molecules, may likewise be utilized.
1o Certain parameters must be adhered to in order to obtain the qualities required for effectiveness.
One step of preparing the electrically activated substance comprises applying a particular electrical signal to the substance. According to the preferred embodiment of the present invention, an alternating current signal, preferably having a generally symmetric waveform, is utilized. Thus, for example, a sinusoidal waveform, a square waveform, or a triangular waveform are suitable. Those skilled in electrical arts will appreciate that various other generally symmetric 2o waveforms are likewise provide alternating current.
The electrical signal preferably comprises an alternating current signal having a particular frequency of between approximately 5 to 10 KHz and approximately 1 MHz, and optimally between approximately 25 KHz and approximately 100 KHz. According to the preferred embodiment of the present invention, the frequency of the electrical signal may also be varied within a frequency range of approximately 50 KHz to 100 KHz.
Preferably, the alternating current has approximately zero 3o direct current bias. In order to mitigate direct current bias, the electrical signal is preferably applied to the substance via a capacitor-resistor network. Alternatively, the electrical signal is applied to the substance via an isolation transformer.
According to the preferred embodiment of the present invention, the electrically activated substance is formed of a water base, preferably distilled water. However, other substances, particularly those comprised of simple molecules, may likewise be utilized.
1o Certain parameters must be adhered to in order to obtain the qualities required for effectiveness.
One step of preparing the electrically activated substance comprises applying a particular electrical signal to the substance. According to the preferred embodiment of the present invention, an alternating current signal, preferably having a generally symmetric waveform, is utilized. Thus, for example, a sinusoidal waveform, a square waveform, or a triangular waveform are suitable. Those skilled in electrical arts will appreciate that various other generally symmetric 2o waveforms are likewise provide alternating current.
The electrical signal preferably comprises an alternating current signal having a particular frequency of between approximately 5 to 10 KHz and approximately 1 MHz, and optimally between approximately 25 KHz and approximately 100 KHz. According to the preferred embodiment of the present invention, the frequency of the electrical signal may also be varied within a frequency range of approximately 50 KHz to 100 KHz.
Preferably, the alternating current has approximately zero 3o direct current bias. In order to mitigate direct current bias, the electrical signal is preferably applied to the substance via a capacitor-resistor network. Alternatively, the electrical signal is applied to the substance via an isolation transformer.
-4-The electrical signal preferably has a voltage of between approximately 50 volts rms and approximately 150 volts rms.
The electrical signal is applied to the substance to be electrically activated via at least one pair of electrodes. As those skilled in the art will appreciate, a plurality of pairs of electrodes may be utilized, if desired. The electrodes are preferably comprised of either a biologically inert, non-reactive metal or a non-metallic material having a low atomic number. For example, it has been found that gold, carbon 6, 1o and graphite-carbon loaded thermo-plastic material are suitable.
When distilled water is to be electrically activated, then a substance is added to the water to so as to form an electrolyte therefrom. This increases the conductivity of the water so as to facilitate adequate current flow therethrough.
According to the preferred embodiment of the present invention, sodium chloride or potassium is utilized to form the electrolyte.
According to the preferred embodiment of the present 2o invention, the substance, e.g., sodium chloride, is added to the distilled water while monitoring current flow therethrough, until the desired current is obtained.
According to a preferred embodiment of the present invention, approximately 1000 milli-amps (1 amp) rms of current is caused to flow through the substance being electrically activated. Typically, a voltage of approximately 100 volts rms is required to effect a current of 1 amp rms. It has been found that currents as low as 1 milliamp may be used with limited results. Preferably, at least 10 milliwatts of power 3o per milliliter of substance as utilized. The electrodes should be shielded from accidental operator contact.
The electrodes preferably have a resistance below 500 ohms per square centimeter, preferably below 50 ohms per square centimeter.
The electrical signal is applied to the substance to be electrically activated via at least one pair of electrodes. As those skilled in the art will appreciate, a plurality of pairs of electrodes may be utilized, if desired. The electrodes are preferably comprised of either a biologically inert, non-reactive metal or a non-metallic material having a low atomic number. For example, it has been found that gold, carbon 6, 1o and graphite-carbon loaded thermo-plastic material are suitable.
When distilled water is to be electrically activated, then a substance is added to the water to so as to form an electrolyte therefrom. This increases the conductivity of the water so as to facilitate adequate current flow therethrough.
According to the preferred embodiment of the present invention, sodium chloride or potassium is utilized to form the electrolyte.
According to the preferred embodiment of the present 2o invention, the substance, e.g., sodium chloride, is added to the distilled water while monitoring current flow therethrough, until the desired current is obtained.
According to a preferred embodiment of the present invention, approximately 1000 milli-amps (1 amp) rms of current is caused to flow through the substance being electrically activated. Typically, a voltage of approximately 100 volts rms is required to effect a current of 1 amp rms. It has been found that currents as low as 1 milliamp may be used with limited results. Preferably, at least 10 milliwatts of power 3o per milliliter of substance as utilized. The electrodes should be shielded from accidental operator contact.
The electrodes preferably have a resistance below 500 ohms per square centimeter, preferably below 50 ohms per square centimeter.
-5-When fully prepared, the substance takes on new physical properties. These properties exhibit stimulative effects when applied to biological tissue.
v~lhen administered topically, approximately 0.05 ml of the electrically activated substance is applied per square centimeter of treatment area. The electrically activated substance is preferably administered 3 to 6 times with approximately 1 to 4 days between administrations.
Such topical application of the electrically activated so substance of the present invention has been found to be effective in mitigating wrinkles on human skin.
When taken orally, approximately 2 ml of the electrically activated substance is preferably ingested per day for approximately 6 weeks.
i5 These, as well as other advantages of the present invention will be more apparent from the following description and drawings. It is understood that changes in the specific structure shown and described may be made within the scope of the claims without departing from the spirit of the invention.
Brief Descrintioa of the DrawiaQs Figure 1 is a perspective view showing a variable frequency current source connected to liquid contained within a beaker;
Figure 2 is a block diagram showing a first alternative configuration of the apparatus of Figure 1;
Figure 3 is a block diagram showing a second alternative configuration of the apparatus of Figure 1;
Figure 4 is a flow chart showing the steps involved in the practice of the method for forming an electrically charged substance, according to the present invention.
Figure 5 illustrates a waveform provided by the current source of Figure 1;
v~lhen administered topically, approximately 0.05 ml of the electrically activated substance is applied per square centimeter of treatment area. The electrically activated substance is preferably administered 3 to 6 times with approximately 1 to 4 days between administrations.
Such topical application of the electrically activated so substance of the present invention has been found to be effective in mitigating wrinkles on human skin.
When taken orally, approximately 2 ml of the electrically activated substance is preferably ingested per day for approximately 6 weeks.
i5 These, as well as other advantages of the present invention will be more apparent from the following description and drawings. It is understood that changes in the specific structure shown and described may be made within the scope of the claims without departing from the spirit of the invention.
Brief Descrintioa of the DrawiaQs Figure 1 is a perspective view showing a variable frequency current source connected to liquid contained within a beaker;
Figure 2 is a block diagram showing a first alternative configuration of the apparatus of Figure 1;
Figure 3 is a block diagram showing a second alternative configuration of the apparatus of Figure 1;
Figure 4 is a flow chart showing the steps involved in the practice of the method for forming an electrically charged substance, according to the present invention.
Figure 5 illustrates a waveform provided by the current source of Figure 1;
-6-Figures 6a illustrates the electrically activated substance being applied to a recipient;
Figure 6b illustrates the recipient after topical application of the substance to treat facial wrinkles;
Figure 7a illustrates a recipient ingesting the substance;
Figure 7b illustrates the recipient after ingesting the substance;
Figures 8a and 8b show a human recipient before and after being dabbed with the electrically charged substance;
1o Figure 9 shows the electrically charged substance being dabbed onto an animal; and Figures 10 and 11 illustrate capillaries and blood vessels in a cross section cutaway of the skin of the recipient.
s5 Detaile8 Descrintioa of the preferred 8mbodimeat The electrically activated substance and method for making the same of the present invention are illustrated in Figures 1 5 of the drawings which depict a presently preferred embodiment 2o thereof.
Referring now to Figure 1, according to the present invention a variable current source 10 is electrically connected, via wires 12 to probes or electrodes 14 which are at least partially immersed within the substance 18 to be 25 electrically activated, which is contained within beaker 16.
The variable frequency current source 10 preferably comprises the variable frequency current source having an output frequency range from approximately 10 KHz to approximately 1 MHz, and a voltage output from approximately 50 3o volts rms to 150 volts rms, and a maximum current output in excess of 1 amp rms.
According to the preferred embodiment of the present invention, the variable frequency current source 10 provides an alternating current output waveform having substantially 0 direct current bias.
The variable frequency current source 10 is capable of providing a generally symmetric waveform, with low or zero DC
bias. This is illustrated in Figure 5. The centerline baseline 38 of Figure 5 represents time. It also indicates zero (o) current flow between the electrodes. The (+) area 40 indicates current flowing in one direction between the electrodes. The (-area 42 indicates current flowing in the opposite direction between electrodes. As shown the current flow between the 1o electrodes reverses direction periodically. The sum of both portions of the waveform are preferably zero. Various other generally symmetrical alternating current waveforms could likewise also be used, such as square, triangular, or other odd shaped waveforms that reverse the direction of current flow.
According to the preferred embodiment of the present invention, the frequency output of the variable frequency current source 10 is capable of being swept or automatically varied between a minimum and maximum frequency. Alternatively, the variable frequency current source 10 is capable of being 2o manually swept in frequency.
The wires 12 preferably comprise copper wires having a current rating sufficient to carry the required current, e.g., 1 amp rms, without excessive heating.
Each electrode 14 is preferably comprised of a chemically and biologically inert material, preferably a non-reactive metal such as gold, or alternatively, a non-metal having a low atomic number. It is believed that it is not desirable to have ions form from the substance of the electrodes. For example, if lead electrodes are utilized, it has been found that lead 3o ions permeate the substance being electrically activated, potentially resulting in undesirable contamination of the medium and potential poisoning of the patient to whom the electrically activated substance is administered. Although aluminum and copper electrodes may be suitable in some _8-applications, they are generally thought to be undesirable.
Carbon has been found to be suitable for the construction of electrodes according to the present invention. Carbon electrodes may be formed utilizing contemporary plastic injection molding techniques wherein a graphite-carbon loaded thermo-plastic material, such as nylon, is injected into the molds, or with other processes.
Typical dimensions for the electrodes 14 are 3 mm thick, 20 mm wide, and 10 cm long. However, various different 1o dimensions and cross-sectional configurations, e.g., round, oval, square, triangular, etc., are likewise useable. Large flat electrodes with a large surface area generally work best.
According to the preferred embodiment of the present invention, the electrical resistance of the finished electrodes is preferably less than 500 ohms/cmz, preferably less than 50 ohms / cmz .
In one embodiment, the two electrodes are positioned several centimeters apart in a 250 ml container, e.g., a beaker. The container is formed of a non-metallic material, 2o such as glass. Thus, as described herein, the method for electrically activating a substance is preferably practiced utilizing approximately 200 ml of the substance at a time.
Preferably, current flow through the substance being electrically conditioned 18 is monitored as an electrolytic substance Figure 1, 8 is added thereto so as to form an electrolyte. The electrolytic substance added improves the flow of current through the substance, so that activation can occur. As the sodium chloride in either crystal or liquid form is added to the water, current flow through the water may be 3o monitored until sufficient current flow is achieved, thereby indicating the proper level of sodium chloride has been added to the water. Potassium or other electrolytic substances may also be used.
According to the preferred embodiment of the present invention, approximately 1 amp rms of current is caused to flow through the substance being electrically activated while a voltage of approximately 100 volts rms is applied thereto.
This provides an optimum power density level for preparing 200 ml of substance at a time. The amount of power used is preferably scaled in approximate proportion to the amount of material being activated at a time.
Typically, current is caused to flow through the substance being electrically activated 18 until small gas bubbles are formed upon the electrodes. This takes approximately 4 to 8 hours. When small gas bubbles are observed on the electrodes, an indication is that the substance has been fully electrically activated and is ready to use. then properly prepared, the electrical signals may then be removed from the substance, and the substance will retain it's activated qualities after removal of the current therethrough. The substance may then be applied to the recipient.
The degree to which the substance becomes electrically activated, and thus the effectiveness thereof in providing 2o cosmetic or medical therapy, is directly related to the voltage applied to the electrodes, the spacing of the electrodes, the current caused to flow between the electrodes, and, to some extent, the length of time that the current is applied.
However, current must be caused to flow between the electrodes for a minimum of at least 10 minutes before any usable results are obtained. Generally, at least 4 hours are required, and at least 8 hours are recommended. Testing indicates that the application of current for a time period much in excess of 8 hours produces little additional effectiveness of the 3o electrically activated substance.
The electrically activated substance is typically active for only a limited amount of time after current flow therethrough has ceased. The electrically activated substance is most effective if utilized within approximately 4 hours after application of the electrical signals. The electrically activated substance is somewhat effective for up to 4 days after its production. It is believed that the decay in the effectiveness of the electrically activated substance is logarithmic in nature, with more than half of the effectiveness thereof lost within approximately 24 hours. After about 7 days, all the active nature of the substance has decayed, and no activated benefit is obtained by the application of the substance to a recipient.
1o The specified values for the applied voltage, duration, and conductivity of the medium may be varied to some degree.
Indeed, a reduction in the effectiveness of the electrically activated substance may be compensated for by varying one or the other of the production parameters.
s5 A lower voltage may be utilized if additional sodium chloride is added to the solution. However, if too much sodium chloride is added, then the solution may become less bio-compatible. Conversely, if less sodium chloride is utilized, then a higher voltage is necessary to obtain sufficient current 2o flow through the substance. If an excessively high voltage is used as the result of an inadequate concentration of electrolytic material in the substance, then the substance will generate excessive heat without an increase in the corresponding activation potential. This results in 25 substantially reduced effectiveness of the electrically activated substance.
It is thought that the electrically activated substance of the present invention provides beneficial cosmetic/medical effects by stimulating a "current of injuryp associated with 3o tissue trauma. then tissue is injured, a small electric current is generated. This current is a result of a voltage producing charge imbalance which occurs when portions of previously connected tissue are disconnected from one another, such as occurs if a bone is broken or skin is torn. This voltage causes a small amount of current, e.g., electrons or ions, to flow from one point to another within the tissue.
The tissue disconnection of an injury simulated by active substance of this device possibly upsets the electrical balance of the biological circuit, thereby resulting in the production of a very small current, typically on the order of nanoamps or less. The presence of this electric current is an instrumental signal in the formation of a blastema, which is a collection of primitive, unformed cells, which gather at an injury site and so are later developed into replacement tissue.
The mechanism whereby the substance becomes active may be related to electrolytic reactions occurring in the substance.
This may be the result of partial separation and recombination of the hydrogen and oxygen atoms. For example, when the waveform is positive Figure 5, 40 oxygen may be formed at one electrode, and hydrogen at the other. The waveform stays positive just long enough to break through double layer effects and begin molecular separation of the gasses. However, before the gasses can fully dissociate and escape the liquid into the 2o atmosphere, the signal reverses direction Figure 5, 42 which "jams" the atoms back together again.
The activating frequency used is between lOKHz to lMhz.
The recommended frequency is preferably between lOKHz and 100KHz, Figure 5b, 44.
It is thought that the active properties of the substance of the present invention effects in biological tissue a disruptive electrical imbalance, similar to that which occurs when a mechanical strain to the tissue has occurred. This electrical imbalance then triggers accelerated metabolic 3o activity in the treatment area. Blood flow accelerates while cellular metabolic activity and interactions increase.
Capillaries dilate and there is increased activity toward restored homeostasis. This is shown in Figures 10 and 11.
In Figure 10, capillaries and small blood vessels 50 are in a relaxed and normal state. In figure 11, beginning a few minutes after application of the electrically active substance, and continuing to a peak about 45 minutes after the application of the substance, the capillaries and small blood vessels 50 swell up and increase the volume and velocity of blood flow through them. This acceleration in blood flow is the first step in the tissue repair and tightening process. On the skin this takes the appearance of a pronounced red blushing or flushing.
Toxins, free radicals, metabolic waste products, and 1o unused remnant material may be re-formed or flushed away. Thus the device and method provide a means to effective treatment that does not rely on the passage of electrical current through the tissue of the recipient.
It is thought that the electrically activated substance of the present invention should not be applied to fresh injury sites, since it may interfere with the timing and development of the natural current of injury, thereby disrupting the healing process. However, once the injury has stabilized, the electrically activated substance of the present invention may 2o be applied thereto so as to enhance or re-activate the healing process.
One exemplary use of the electrically activated substance of the present invention is the removal of skin wrinkles. For example, facial wrinkles may be treated with the electrically activated water. This is shown in figure 8. In Figure 8a, the active substance 18 is dabbed on to the skin using a sponge or similar applicator. It may also be spritzed or dabbed onto the skin for topical application thereto. Both wrinkled 46 and unwrinkled areas may be treated. The typical dose rate is 3o approximately 0.05 ml/cm2 of treatment area. The tightening effect that occurs on the non-wrinkled areas will still help tighten the wrinkled areas. Mitigation of skin wrinkles typically occurs beginning within approximately 30 minutes, with the results being clearly visible.
Preferably, the water is activated with a frequency of between approximately 50 KHz and 100 KHz. It has been found that such electrically activated water is particularly beneficial to the skin and other soft tissue.
Blood flow and metabolic activity accelerates and has been found to peak within approximately 45 minutes after the application of the electrically activated substance of the present invention. After this period of increased blood flow and accelerated metabolism, the skin and tissue enters a so recovery phase wherein the cellular structure thereof is rebuilt.
This recovery phase typically has a duration of approximately one to four days. Skin begins to draw together, getting tighter, thicker, and causing wrinkles to shrink.
s5 Additional collagen forms at the site of treatment. There may be heavy itching, but no pain. After four days, approximately all such recovery has occurred. At the end of the recovery phase, another treatment may be applied. It has been found that the recovery phase must be complete before a subsequent 2o treatment, so as to avoid overwhelming the response mechanism.
It is believed that the improvements obtained via the use of the present invention are essentially permanent in nature.
That is, it is believed that new wrinkles will take almost as long to form as the original ones did.
25 Approximately six such treatment sessions are typically required for the optimum removal of wrinkles. After the first treatment session, at least some, occasionally most or all of the fine line facial wrinkles of 1 mm or less in size are either reduced in size or eliminated altogether. After three 3o to four treatment sessions, wrinkles of up to four mm in size are typically substantially reduced. After approximately six treatment sessions, many, if not most or all of the facial wrinkles, including large wrinkles of the forehead are typically substantially eliminated. Typically, six treatment sessions, at one session per week for six weeks, are utilized.
The more degenerated the skin, the more dramatic the results are. Acne is frequently cleared in the process due to increased blood flow. Thus, the general result is renewed skin or tissue, without surgery, grafting, patchwork, dermabrasion, laser vaporization, or other invasive or mechanical techniques.
As a result of such treatments, enhanced elastin and collagen support is provided and typical age sagging is reduced due to the shrinking of the skin by as much as ten to twenty 1o percent. This is illustrated in Figure 8b. The skin is tighter, thicker, and wrinkles 46 are diminished quite noticeably.
It has also been found that therapeutic medical benefits may be obtained if the medium is ingested. In Figure 7a the substance 18 is ingested orally. Wrinkles 46 are gradually diminished over a period of time. In Figure 7b the skin becomes much more smooth overall, with wrinkles 46 diminished. When taken orally, the dose rate is preferably comparatively small, approximately 2 ml per day for 6 weeks. It is thought that 2o such therapy is also beneficial for heart, digestion, and circulatory problems. The substance may also be applied or ingested to treat a variety of other conditions, not just wrinkles.
To further appreciate the unique advantages of this process, consider that this technique has been also found at least partially effective in the conversion of surgical scar tissue from a typically necrid white fibrous collagen material back into normal healthy pink skin with nerve sensitivity, blood vessels, and even hair follicles. These results may be obtained with administration of a daily to semi-daily topical application, typically over a 6 month period. As the collagen is initially resistant to absorbing the medium, a vasodilator additive is effective in speeding results by increasing penetration of the medium.
Moreover, the techniques described herein are also applicable to animals. Figure 9 shows an example where the substance 18 is applied to a canine 48. Health benefits may be obtained from the enhanced circulation.
Because the electrically activated substance of the present invention functions as a transfer agent or medium, at no time is there any current flow from the variable frequency current source through biological tissue. Thus, there is no chance of burns, thereby enhancing the safety of such treatment 1o compared to traditional transcutaneous electrotherapy or laser.
Referring now to Figures 2 and 3, if the variable frequency current source 10 does not provide approximately 0 direct current bias, then the output thereof can be processed so as to mitigate direct current bias. Zero DC bias is important in the activation signal. Without a zero or low DC
bias in the activation signal, the substance will not take on it's therapeutic properties.
With particular reference to Figure 2, a resistor capacitor network 22 filters the output of the variable 2o frequency current source 10, so as to mitigate direct current bias. Such a resistor-capacitor network comprises at least one capacitor 26 in series with the substance being electrically activated and at least one resistor 28 in parallel therewith.
The resistor-capacitor network 22 functions according to known electrical principles to mitigate the presence of DC bias in the substance being electrically charged. Those skilled in the art will appreciate that various other types of filters may be utilized. For example, a capacitor inductor network may be utilized. Also, the resistor 28 may often be deleted if the 3o resistance of the substance 18 between the two electrodes is sufficiently small so as to form the resistor portion of the circuit.
With particular reference to Figure 3, an isolation transformer 24 isolates the substance 18 to be electrically charged from direct current bias present in the output of the variable frequency current source 10.
In any instance, when the variable frequency current source 10 does not include a means for monitoring current flow through the substance 18 being electrically activated, then such means is preferably included in the electrical path of the electrodes 14. For example, an amp meter 20 may be inserted in line or applied inductively to one of the wires 12 which provide an electrical pathway for the current which travels 1o between the electrodes 14. Alternatively, an oscilloscope may be utilized to monitor current flow between the electrodes 14.
Referring now to Figure 4, the method for forming an electrically activated substance of the present invention generally comprises providing distilled water 30, adding sodium chloride to the distilled water to form an electrolyte 32, monitoring current flow between the electrodes if desired 32, applying the alternating current to the electrodes 34, and, removing the current and administering the electrically activated substance 36, preferably within seven days after the 2o electrical activation thereof. The application of alternating current 34 to the substance to be electrically charged preferably takes place for a duration of approximately at least 4 to 8 hours.
The electric current is applied to the intermediate material, (i.e., the electrically activated substance), rather than directly to a person. Thus, a substantial amount of more power may be applied to the electrically activated substance rather than directly to a person. Indeed, according to the preferred embodiment of the present invention, much more power, (e.g., approximately 100 watts), can be applied to the electrically activated substance than could be tolerated by a human being.
The minimum amount of electrical power applied to the substance during activation thereof must be sufficient to overcome the activation decay rate of the substance. It has been found that the approximate minimum amount of power that can be used and still obtain any result is approximately 10 milliwatts per milliliter of substance. The application of approximately 100 watts of electrical power to 200 ml of water results in an acceptable decay rate.
The actual voltage and power used should be of a level sufficient to raise the temperature of the substance being electrically activated by at least three, and preferably thirty 1o to fifty degrees centigrade above ambient. If the substance temperature should rise excessively, to about the boiling point of the substance, excessive power is being used, and the activation qualities dissipate. (The substance losses it's activation effectiveness if boiled.) i5 Due to the relatively large amount of power used to electrically activate the water, a relatively high frequency is used. In this way, premature electrolysis (gassing) of the water is avoided. The high frequency also accelerates electron agitation in the medium. The pH balance of the medium is 2o essentially unchanged.
Non-distilled or tap water or other bio-compatible compounds, including tissue and fluids, may be possibly be utilized instead of distilled water. However, the types and amounts of impurities found in tap water vary considerably from 25 one location to another. Most tap water has been found to not contain sufficient impurities to support adequate current flow therethrough. Best results are obtained with an electrolytic additive to the water.
The electrically activated substance is created using the 3o power levels, frequencies, current densities, and dosage quantities described herein, or parameters similar to those described herein. 4~hen the substance is produced in this manner, it takes on unique properties (possibly on an atomic level), which make it particularly well suited for the practice of the present invention.
Those skilled in the art will appreciate that various other electrolyte forming substances, other than sodium chloride are likewise suitable. The substance may be applied to treat a variety of conditions, not just wrinkles.
It is understood that the exemplary electrically activated substance and method for making the same described herein and shown in the drawings represents only a preferred embodiment of the invention. Indeed, various modifications and additions may 1o be made to such embodiment without departing from the spirit and scope of the invention. For example, various different sizes, shapes, and configurations of the container, the electrodes, and the source and waveform of alternating current are contemplated. Further, as those skilled in the art will appreciate, the use of water as the electrically activated substance is by way of example only, not by way of limitation.
Thus the method provides therapeutic medical and cosmetic benefits without relying on surgical or laser or dermabrasion techniques, and without relying on the passage of electrical 2o signal current through the tissue of the recipient.
The description sets forth the steps for constructing and operating the invention in connection with the illustrated embodiment. It is to be understood, however, that the same or equivalent functions and sequences may be accomplished by different embodiments that are also intended to be encompassed within the spirit and scope of the invention.
Figure 6b illustrates the recipient after topical application of the substance to treat facial wrinkles;
Figure 7a illustrates a recipient ingesting the substance;
Figure 7b illustrates the recipient after ingesting the substance;
Figures 8a and 8b show a human recipient before and after being dabbed with the electrically charged substance;
1o Figure 9 shows the electrically charged substance being dabbed onto an animal; and Figures 10 and 11 illustrate capillaries and blood vessels in a cross section cutaway of the skin of the recipient.
s5 Detaile8 Descrintioa of the preferred 8mbodimeat The electrically activated substance and method for making the same of the present invention are illustrated in Figures 1 5 of the drawings which depict a presently preferred embodiment 2o thereof.
Referring now to Figure 1, according to the present invention a variable current source 10 is electrically connected, via wires 12 to probes or electrodes 14 which are at least partially immersed within the substance 18 to be 25 electrically activated, which is contained within beaker 16.
The variable frequency current source 10 preferably comprises the variable frequency current source having an output frequency range from approximately 10 KHz to approximately 1 MHz, and a voltage output from approximately 50 3o volts rms to 150 volts rms, and a maximum current output in excess of 1 amp rms.
According to the preferred embodiment of the present invention, the variable frequency current source 10 provides an alternating current output waveform having substantially 0 direct current bias.
The variable frequency current source 10 is capable of providing a generally symmetric waveform, with low or zero DC
bias. This is illustrated in Figure 5. The centerline baseline 38 of Figure 5 represents time. It also indicates zero (o) current flow between the electrodes. The (+) area 40 indicates current flowing in one direction between the electrodes. The (-area 42 indicates current flowing in the opposite direction between electrodes. As shown the current flow between the 1o electrodes reverses direction periodically. The sum of both portions of the waveform are preferably zero. Various other generally symmetrical alternating current waveforms could likewise also be used, such as square, triangular, or other odd shaped waveforms that reverse the direction of current flow.
According to the preferred embodiment of the present invention, the frequency output of the variable frequency current source 10 is capable of being swept or automatically varied between a minimum and maximum frequency. Alternatively, the variable frequency current source 10 is capable of being 2o manually swept in frequency.
The wires 12 preferably comprise copper wires having a current rating sufficient to carry the required current, e.g., 1 amp rms, without excessive heating.
Each electrode 14 is preferably comprised of a chemically and biologically inert material, preferably a non-reactive metal such as gold, or alternatively, a non-metal having a low atomic number. It is believed that it is not desirable to have ions form from the substance of the electrodes. For example, if lead electrodes are utilized, it has been found that lead 3o ions permeate the substance being electrically activated, potentially resulting in undesirable contamination of the medium and potential poisoning of the patient to whom the electrically activated substance is administered. Although aluminum and copper electrodes may be suitable in some _8-applications, they are generally thought to be undesirable.
Carbon has been found to be suitable for the construction of electrodes according to the present invention. Carbon electrodes may be formed utilizing contemporary plastic injection molding techniques wherein a graphite-carbon loaded thermo-plastic material, such as nylon, is injected into the molds, or with other processes.
Typical dimensions for the electrodes 14 are 3 mm thick, 20 mm wide, and 10 cm long. However, various different 1o dimensions and cross-sectional configurations, e.g., round, oval, square, triangular, etc., are likewise useable. Large flat electrodes with a large surface area generally work best.
According to the preferred embodiment of the present invention, the electrical resistance of the finished electrodes is preferably less than 500 ohms/cmz, preferably less than 50 ohms / cmz .
In one embodiment, the two electrodes are positioned several centimeters apart in a 250 ml container, e.g., a beaker. The container is formed of a non-metallic material, 2o such as glass. Thus, as described herein, the method for electrically activating a substance is preferably practiced utilizing approximately 200 ml of the substance at a time.
Preferably, current flow through the substance being electrically conditioned 18 is monitored as an electrolytic substance Figure 1, 8 is added thereto so as to form an electrolyte. The electrolytic substance added improves the flow of current through the substance, so that activation can occur. As the sodium chloride in either crystal or liquid form is added to the water, current flow through the water may be 3o monitored until sufficient current flow is achieved, thereby indicating the proper level of sodium chloride has been added to the water. Potassium or other electrolytic substances may also be used.
According to the preferred embodiment of the present invention, approximately 1 amp rms of current is caused to flow through the substance being electrically activated while a voltage of approximately 100 volts rms is applied thereto.
This provides an optimum power density level for preparing 200 ml of substance at a time. The amount of power used is preferably scaled in approximate proportion to the amount of material being activated at a time.
Typically, current is caused to flow through the substance being electrically activated 18 until small gas bubbles are formed upon the electrodes. This takes approximately 4 to 8 hours. When small gas bubbles are observed on the electrodes, an indication is that the substance has been fully electrically activated and is ready to use. then properly prepared, the electrical signals may then be removed from the substance, and the substance will retain it's activated qualities after removal of the current therethrough. The substance may then be applied to the recipient.
The degree to which the substance becomes electrically activated, and thus the effectiveness thereof in providing 2o cosmetic or medical therapy, is directly related to the voltage applied to the electrodes, the spacing of the electrodes, the current caused to flow between the electrodes, and, to some extent, the length of time that the current is applied.
However, current must be caused to flow between the electrodes for a minimum of at least 10 minutes before any usable results are obtained. Generally, at least 4 hours are required, and at least 8 hours are recommended. Testing indicates that the application of current for a time period much in excess of 8 hours produces little additional effectiveness of the 3o electrically activated substance.
The electrically activated substance is typically active for only a limited amount of time after current flow therethrough has ceased. The electrically activated substance is most effective if utilized within approximately 4 hours after application of the electrical signals. The electrically activated substance is somewhat effective for up to 4 days after its production. It is believed that the decay in the effectiveness of the electrically activated substance is logarithmic in nature, with more than half of the effectiveness thereof lost within approximately 24 hours. After about 7 days, all the active nature of the substance has decayed, and no activated benefit is obtained by the application of the substance to a recipient.
1o The specified values for the applied voltage, duration, and conductivity of the medium may be varied to some degree.
Indeed, a reduction in the effectiveness of the electrically activated substance may be compensated for by varying one or the other of the production parameters.
s5 A lower voltage may be utilized if additional sodium chloride is added to the solution. However, if too much sodium chloride is added, then the solution may become less bio-compatible. Conversely, if less sodium chloride is utilized, then a higher voltage is necessary to obtain sufficient current 2o flow through the substance. If an excessively high voltage is used as the result of an inadequate concentration of electrolytic material in the substance, then the substance will generate excessive heat without an increase in the corresponding activation potential. This results in 25 substantially reduced effectiveness of the electrically activated substance.
It is thought that the electrically activated substance of the present invention provides beneficial cosmetic/medical effects by stimulating a "current of injuryp associated with 3o tissue trauma. then tissue is injured, a small electric current is generated. This current is a result of a voltage producing charge imbalance which occurs when portions of previously connected tissue are disconnected from one another, such as occurs if a bone is broken or skin is torn. This voltage causes a small amount of current, e.g., electrons or ions, to flow from one point to another within the tissue.
The tissue disconnection of an injury simulated by active substance of this device possibly upsets the electrical balance of the biological circuit, thereby resulting in the production of a very small current, typically on the order of nanoamps or less. The presence of this electric current is an instrumental signal in the formation of a blastema, which is a collection of primitive, unformed cells, which gather at an injury site and so are later developed into replacement tissue.
The mechanism whereby the substance becomes active may be related to electrolytic reactions occurring in the substance.
This may be the result of partial separation and recombination of the hydrogen and oxygen atoms. For example, when the waveform is positive Figure 5, 40 oxygen may be formed at one electrode, and hydrogen at the other. The waveform stays positive just long enough to break through double layer effects and begin molecular separation of the gasses. However, before the gasses can fully dissociate and escape the liquid into the 2o atmosphere, the signal reverses direction Figure 5, 42 which "jams" the atoms back together again.
The activating frequency used is between lOKHz to lMhz.
The recommended frequency is preferably between lOKHz and 100KHz, Figure 5b, 44.
It is thought that the active properties of the substance of the present invention effects in biological tissue a disruptive electrical imbalance, similar to that which occurs when a mechanical strain to the tissue has occurred. This electrical imbalance then triggers accelerated metabolic 3o activity in the treatment area. Blood flow accelerates while cellular metabolic activity and interactions increase.
Capillaries dilate and there is increased activity toward restored homeostasis. This is shown in Figures 10 and 11.
In Figure 10, capillaries and small blood vessels 50 are in a relaxed and normal state. In figure 11, beginning a few minutes after application of the electrically active substance, and continuing to a peak about 45 minutes after the application of the substance, the capillaries and small blood vessels 50 swell up and increase the volume and velocity of blood flow through them. This acceleration in blood flow is the first step in the tissue repair and tightening process. On the skin this takes the appearance of a pronounced red blushing or flushing.
Toxins, free radicals, metabolic waste products, and 1o unused remnant material may be re-formed or flushed away. Thus the device and method provide a means to effective treatment that does not rely on the passage of electrical current through the tissue of the recipient.
It is thought that the electrically activated substance of the present invention should not be applied to fresh injury sites, since it may interfere with the timing and development of the natural current of injury, thereby disrupting the healing process. However, once the injury has stabilized, the electrically activated substance of the present invention may 2o be applied thereto so as to enhance or re-activate the healing process.
One exemplary use of the electrically activated substance of the present invention is the removal of skin wrinkles. For example, facial wrinkles may be treated with the electrically activated water. This is shown in figure 8. In Figure 8a, the active substance 18 is dabbed on to the skin using a sponge or similar applicator. It may also be spritzed or dabbed onto the skin for topical application thereto. Both wrinkled 46 and unwrinkled areas may be treated. The typical dose rate is 3o approximately 0.05 ml/cm2 of treatment area. The tightening effect that occurs on the non-wrinkled areas will still help tighten the wrinkled areas. Mitigation of skin wrinkles typically occurs beginning within approximately 30 minutes, with the results being clearly visible.
Preferably, the water is activated with a frequency of between approximately 50 KHz and 100 KHz. It has been found that such electrically activated water is particularly beneficial to the skin and other soft tissue.
Blood flow and metabolic activity accelerates and has been found to peak within approximately 45 minutes after the application of the electrically activated substance of the present invention. After this period of increased blood flow and accelerated metabolism, the skin and tissue enters a so recovery phase wherein the cellular structure thereof is rebuilt.
This recovery phase typically has a duration of approximately one to four days. Skin begins to draw together, getting tighter, thicker, and causing wrinkles to shrink.
s5 Additional collagen forms at the site of treatment. There may be heavy itching, but no pain. After four days, approximately all such recovery has occurred. At the end of the recovery phase, another treatment may be applied. It has been found that the recovery phase must be complete before a subsequent 2o treatment, so as to avoid overwhelming the response mechanism.
It is believed that the improvements obtained via the use of the present invention are essentially permanent in nature.
That is, it is believed that new wrinkles will take almost as long to form as the original ones did.
25 Approximately six such treatment sessions are typically required for the optimum removal of wrinkles. After the first treatment session, at least some, occasionally most or all of the fine line facial wrinkles of 1 mm or less in size are either reduced in size or eliminated altogether. After three 3o to four treatment sessions, wrinkles of up to four mm in size are typically substantially reduced. After approximately six treatment sessions, many, if not most or all of the facial wrinkles, including large wrinkles of the forehead are typically substantially eliminated. Typically, six treatment sessions, at one session per week for six weeks, are utilized.
The more degenerated the skin, the more dramatic the results are. Acne is frequently cleared in the process due to increased blood flow. Thus, the general result is renewed skin or tissue, without surgery, grafting, patchwork, dermabrasion, laser vaporization, or other invasive or mechanical techniques.
As a result of such treatments, enhanced elastin and collagen support is provided and typical age sagging is reduced due to the shrinking of the skin by as much as ten to twenty 1o percent. This is illustrated in Figure 8b. The skin is tighter, thicker, and wrinkles 46 are diminished quite noticeably.
It has also been found that therapeutic medical benefits may be obtained if the medium is ingested. In Figure 7a the substance 18 is ingested orally. Wrinkles 46 are gradually diminished over a period of time. In Figure 7b the skin becomes much more smooth overall, with wrinkles 46 diminished. When taken orally, the dose rate is preferably comparatively small, approximately 2 ml per day for 6 weeks. It is thought that 2o such therapy is also beneficial for heart, digestion, and circulatory problems. The substance may also be applied or ingested to treat a variety of other conditions, not just wrinkles.
To further appreciate the unique advantages of this process, consider that this technique has been also found at least partially effective in the conversion of surgical scar tissue from a typically necrid white fibrous collagen material back into normal healthy pink skin with nerve sensitivity, blood vessels, and even hair follicles. These results may be obtained with administration of a daily to semi-daily topical application, typically over a 6 month period. As the collagen is initially resistant to absorbing the medium, a vasodilator additive is effective in speeding results by increasing penetration of the medium.
Moreover, the techniques described herein are also applicable to animals. Figure 9 shows an example where the substance 18 is applied to a canine 48. Health benefits may be obtained from the enhanced circulation.
Because the electrically activated substance of the present invention functions as a transfer agent or medium, at no time is there any current flow from the variable frequency current source through biological tissue. Thus, there is no chance of burns, thereby enhancing the safety of such treatment 1o compared to traditional transcutaneous electrotherapy or laser.
Referring now to Figures 2 and 3, if the variable frequency current source 10 does not provide approximately 0 direct current bias, then the output thereof can be processed so as to mitigate direct current bias. Zero DC bias is important in the activation signal. Without a zero or low DC
bias in the activation signal, the substance will not take on it's therapeutic properties.
With particular reference to Figure 2, a resistor capacitor network 22 filters the output of the variable 2o frequency current source 10, so as to mitigate direct current bias. Such a resistor-capacitor network comprises at least one capacitor 26 in series with the substance being electrically activated and at least one resistor 28 in parallel therewith.
The resistor-capacitor network 22 functions according to known electrical principles to mitigate the presence of DC bias in the substance being electrically charged. Those skilled in the art will appreciate that various other types of filters may be utilized. For example, a capacitor inductor network may be utilized. Also, the resistor 28 may often be deleted if the 3o resistance of the substance 18 between the two electrodes is sufficiently small so as to form the resistor portion of the circuit.
With particular reference to Figure 3, an isolation transformer 24 isolates the substance 18 to be electrically charged from direct current bias present in the output of the variable frequency current source 10.
In any instance, when the variable frequency current source 10 does not include a means for monitoring current flow through the substance 18 being electrically activated, then such means is preferably included in the electrical path of the electrodes 14. For example, an amp meter 20 may be inserted in line or applied inductively to one of the wires 12 which provide an electrical pathway for the current which travels 1o between the electrodes 14. Alternatively, an oscilloscope may be utilized to monitor current flow between the electrodes 14.
Referring now to Figure 4, the method for forming an electrically activated substance of the present invention generally comprises providing distilled water 30, adding sodium chloride to the distilled water to form an electrolyte 32, monitoring current flow between the electrodes if desired 32, applying the alternating current to the electrodes 34, and, removing the current and administering the electrically activated substance 36, preferably within seven days after the 2o electrical activation thereof. The application of alternating current 34 to the substance to be electrically charged preferably takes place for a duration of approximately at least 4 to 8 hours.
The electric current is applied to the intermediate material, (i.e., the electrically activated substance), rather than directly to a person. Thus, a substantial amount of more power may be applied to the electrically activated substance rather than directly to a person. Indeed, according to the preferred embodiment of the present invention, much more power, (e.g., approximately 100 watts), can be applied to the electrically activated substance than could be tolerated by a human being.
The minimum amount of electrical power applied to the substance during activation thereof must be sufficient to overcome the activation decay rate of the substance. It has been found that the approximate minimum amount of power that can be used and still obtain any result is approximately 10 milliwatts per milliliter of substance. The application of approximately 100 watts of electrical power to 200 ml of water results in an acceptable decay rate.
The actual voltage and power used should be of a level sufficient to raise the temperature of the substance being electrically activated by at least three, and preferably thirty 1o to fifty degrees centigrade above ambient. If the substance temperature should rise excessively, to about the boiling point of the substance, excessive power is being used, and the activation qualities dissipate. (The substance losses it's activation effectiveness if boiled.) i5 Due to the relatively large amount of power used to electrically activate the water, a relatively high frequency is used. In this way, premature electrolysis (gassing) of the water is avoided. The high frequency also accelerates electron agitation in the medium. The pH balance of the medium is 2o essentially unchanged.
Non-distilled or tap water or other bio-compatible compounds, including tissue and fluids, may be possibly be utilized instead of distilled water. However, the types and amounts of impurities found in tap water vary considerably from 25 one location to another. Most tap water has been found to not contain sufficient impurities to support adequate current flow therethrough. Best results are obtained with an electrolytic additive to the water.
The electrically activated substance is created using the 3o power levels, frequencies, current densities, and dosage quantities described herein, or parameters similar to those described herein. 4~hen the substance is produced in this manner, it takes on unique properties (possibly on an atomic level), which make it particularly well suited for the practice of the present invention.
Those skilled in the art will appreciate that various other electrolyte forming substances, other than sodium chloride are likewise suitable. The substance may be applied to treat a variety of conditions, not just wrinkles.
It is understood that the exemplary electrically activated substance and method for making the same described herein and shown in the drawings represents only a preferred embodiment of the invention. Indeed, various modifications and additions may 1o be made to such embodiment without departing from the spirit and scope of the invention. For example, various different sizes, shapes, and configurations of the container, the electrodes, and the source and waveform of alternating current are contemplated. Further, as those skilled in the art will appreciate, the use of water as the electrically activated substance is by way of example only, not by way of limitation.
Thus the method provides therapeutic medical and cosmetic benefits without relying on surgical or laser or dermabrasion techniques, and without relying on the passage of electrical 2o signal current through the tissue of the recipient.
The description sets forth the steps for constructing and operating the invention in connection with the illustrated embodiment. It is to be understood, however, that the same or equivalent functions and sequences may be accomplished by different embodiments that are also intended to be encompassed within the spirit and scope of the invention.
Claims (31)
1. A method of preparing and use of a substance comprising the following steps:
connecting a current source to at least one pair of electrodes and spacing said pair of electrodes apart from one another in a container having an electrically conductive liquid, such that said electrically conductive liquid is separated from the body area of a human recipient to be treated;
operating said current source to generate an alternating current having substantially no direct current bias and a frequency lying in a range of frequencies between 10KHz and 1Mhz so as to flow alternating current through said electrically conductive liquid and between said pair of electrodes for at least 10 minutes; and removing said alternating current flow through said electrically conductive liquid after said at least 10 minutes;
and applying said electrically treated conductive liquid to the recipient within 7 days of removing said current flow through said liquid.
connecting a current source to at least one pair of electrodes and spacing said pair of electrodes apart from one another in a container having an electrically conductive liquid, such that said electrically conductive liquid is separated from the body area of a human recipient to be treated;
operating said current source to generate an alternating current having substantially no direct current bias and a frequency lying in a range of frequencies between 10KHz and 1Mhz so as to flow alternating current through said electrically conductive liquid and between said pair of electrodes for at least 10 minutes; and removing said alternating current flow through said electrically conductive liquid after said at least 10 minutes;
and applying said electrically treated conductive liquid to the recipient within 7 days of removing said current flow through said liquid.
2. The method as recited in claim 1, wherein the said electrically conductive substance is applied to the face of the recipient, to smooth facial wrinkles of the recipient, following the removal of said alternating current flow through said electrically conductive liquid.
3. The method as recited in claim 1, wherein the said prepared liquid is applied to the skin of the recipient, to smooth wrinkles of the recipient, following the removal of said alternating current flow through said electrically conductive liquid.
4. The method as recited in claim 1, wherein the said prepared electrically conductive liquid is applied to the skin of the recipient, for purposes of treating a condition of the recipient, following the removal of said alternating current flow through said electrically conductive liquid.
5. The method as recited in claim 1, wherein the said electrically conductive liquid is orally ingested by the recipient, following the removal of said alternating current flow through said electrically conductive liquid.
6. The method is recited in claim 1, wherein the said prepared electrically conductive liquid is orally ingested by the recipient, to smooth facial wrinkles of the recipient, following the removal of said alternating current flow through said electrically conductive liquid.
7. The method as recited in claim 1, wherein the said prepared liquid is orally ingested by the recipient, for purposes of treating an internal condition of the recipient, following the removal of said alternating current flow through said electrically conductive liquid.
8. The method as recited in claim 1, wherein the said electrically conductive liquid is orally ingested by the recipient at approximately 2 ml of said electrically conductive liquid per day for approximately six weeks following the removal of said alternating current flow through said electrically conductive liquid.
9. The method as recited in claim 1, wherein the output power of said current source is at least approximately 10 milliwatts per millilitre of said electrically conductive fluid in said container.
10. The method as recited in claim 1, wherein the output power of said current source is at least enough to raise the temperature of the electrically conductive substance by at least three degrees centigrade above ambient.
11. The method as recited in claim 10, wherein the prepared liquid is applied to the skin of the recipient, following the removal of said alternating current flow through said electrically conductive liquid.
12. The method as recited in claim 9, wherein the prepared liquid is applied to the skin of the recipient, to smooth wrinkles of the recipient, following the removal of said alternating current flow through said electrically conductive liquid.
13. The method as recited in claim 10, wherein the said prepared liquid is orally ingested by the recipient, for purposes of tracing a condition of the recipient, following the removal of said alternating current flow through said electrically conductive liquid.
14. The method as recited in claim 10, wherein the prepared liquid is orally ingested the recipient, to smooth wrinkles of the recipient, following the removal of said alternating current flow through said electrically conductive liquid.
15. The method recited in claim 10, wherein the recipient is an animal.
16. The method recited in claim 1, wherein the recipient is an animal.
17. The method recited in claim 1, wherein the recipient is an animal, and the fluid substance is orally ingested by the animal, for purposes of treating a condition of the animal.
18. The method as recited in claim 1, wherein the said electrically conductive liquid is water to which sodium chloride has been added.
19. The method as recited in claim 1, wherein the said electrically conductive liquid is water to which an electrolytic material has been added.
20. The method recited in claim 1, wherein the electrically conductive fluid is applied to scar tissue of the recipient, for purposes of diminishing the scar tissue.
21. The method as recited in claim 1, wherein the said current source generates approximately 1 amp of alternating current at approximately 100 volts to be applied to said pair of electrodes in said electrically conductive liquid for at least 10 minutes.
22. The method as recited in claim 1, wherein the alternating current generated by said current source and applied to said electrically conductive liquid has a frequency that lies in the range of frequencies between 50 KHz to 100KHz.
23. The method as recited in claim 22, wherein the said prepared liquid is orally ingested by the recipient, following the removal of said alternating current flow through said electrically conductive liquid.
24. The method as recited in claim 1, wherein the alternating current generated by said current source and applied to said electrically conductive liquid has a frequency that lies in the range of frequencies between 10KHz to 200KHz.
25. The method as recited in claim 24, wherein the said prepared liquid is applied to the skin of the recipient, to smooth wrinkles of the recipient, following the removal of said alternating current flow through said electrically conductive liquid.
26. The method as recited in claim 24, wherein the said prepared liquid is orally ingested by the recipient, for purposes of tracing a condition of the recipient, following the removal of said alternating current flow through said electrically conductive liquid.
27. The method as recited in claim 1, wherein the alternating current source has a variable frequency.
28. The method as recited in claim 1, including the additional step of migrating direct current bias from said current source to said electrically conductive liquid by attaching a filter network between said current source and said pair of electrodes, said filter network including a capacitor connected in electrical series between said current source and said electrodes, and a resistive element connected with said capacitor and in electrical parallel between said pair of electrodes.
29. The method as recited in claim 1, including the additional step of isolating said electrically conductive liquid from direct current bias of said current source by connecting an isolation transformer between said current source and said pair of electrodes.
30. The method as recited in claim 1, including the additional step of monitoring the magnitude of the alternating current flow generated by said current source to said electrically conductive fluid.
31. The method as recited in claim 1, wherein the said current source has an output voltage that lies in a range of voltages between approximately 50 volts to 150 volts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2291352 CA2291352A1 (en) | 1999-12-01 | 1999-12-01 | Method of providing cosmetic/medical therapy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2291352 CA2291352A1 (en) | 1999-12-01 | 1999-12-01 | Method of providing cosmetic/medical therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2291352A1 true CA2291352A1 (en) | 2001-06-01 |
Family
ID=4164767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2291352 Abandoned CA2291352A1 (en) | 1999-12-01 | 1999-12-01 | Method of providing cosmetic/medical therapy |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2291352A1 (en) |
-
1999
- 1999-12-01 CA CA 2291352 patent/CA2291352A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20050217682A1 (en) | Method of providing cosmetic/medical therapy | |
| ES2041603T1 (en) | APPARATUS AND METHOD FOR TRANSCRANIAL ELECTROTHERAPY. | |
| Konikoff | Electrical promotion of soft tissue repairs | |
| Graves | Lessons from tesla for plasma medicine | |
| US5885241A (en) | Treatment with an electrically-activated substance | |
| US6488032B1 (en) | Method of providing cosmetic/medical therapy | |
| AU752905B2 (en) | Electrically activated substance and method for making same | |
| CA2291352A1 (en) | Method of providing cosmetic/medical therapy | |
| JP2700242B2 (en) | Disease treatment equipment | |
| Driban | Bone Stimulators and Microcurrent: Clinical Bioelectrics. | |
| CA2291559A1 (en) | Alternating current prepared medicament and uses thereof | |
| WO1995029732A1 (en) | Multiple needle electrode | |
| MXPA01010024A (en) | Method of providing cosmetic/medical therapy | |
| Massey | Practical electrotherapeutics and diathermy | |
| Turrell | The principles of electrotherapy and their practical application | |
| SU1074542A1 (en) | Method of treatment of radiculitis | |
| KR900005855B1 (en) | Stimulating apparatus for growth and revival of hair | |
| Elliott | Electro-therapeutics and X-rays | |
| Redding | Aids to Electro-therapeutics | |
| SU1207472A1 (en) | Method and apparatus for local anesthesia | |
| Braun III | A Journal For Physicians By Physicians | |
| Morgan | Electrothermic Methods (desiccation and Coagulation) in the Treatment of Neoplastic Diseases: Designed as a Practical Handbook of Surgical Electrotherapy for the Use of Practitioners and Students | |
| Matijaca | Principles of Electro-medicine, Electro-surgery and Radiology: A Practical Treatise for Students and Practioners, with Chapters on Mechanical Vibration and Blood Pressure Technique | |
| LooMs et al. | Electřicity, hē sāid, hād bēēn intrödücēd into theräpeti. | |
| Waddington | Practical Index to Electro-physiotherapy: With Index of Diseases and Discriptive Techniques |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDC | Correction of dead application (reinstatement) | ||
| FZDE | Dead |
Effective date: 20141202 |